Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy
- PMID: 32280209
- PMCID: PMC7132005
- DOI: 10.2147/COPD.S237228
Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy
Erratum in
-
Erratum: Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum].Int J Chron Obstruct Pulmon Dis. 2021 Nov 4;16:3017-3018. doi: 10.2147/COPD.S346814. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34764644 Free PMC article.
Abstract
Purpose: Evidence suggests that chronic obstructive pulmonary disease (COPD) symptoms and progression may differ between men and women. However, limited information is currently available on the pathophysiological and biological factors that may underlie these sex-related differences. The objective of this review is to systematically evaluate reports of potential sex-related differences, including genetic, pathophysiological, structural, and other biological factors, that may influence COPD development, manifestation, and progression in women.
Patients and methods: A PubMed literature search was conducted from inception until January 2020. Original reports of genetic, hormonal, and physiological differences, and biological influences that could contribute to COPD development, manifestation, and progression in women were included.
Results: Overall, 491 articles were screened; 29 articles met the inclusion criteria. Results from this analysis demonstrated between-sex differences in inflammatory, immune, genetic, structural, and physiological factors in patients with COPD.
Conclusion: Various biological differences are observed between men and women with COPD including differences in inflammatory and metabolic pathways related to obesity and fat distribution, immune cell function and autophagy, extent and distribution of emphysema and airway wall remodeling. An enhanced understanding of these differences has the potential to broaden our understanding of how COPD develops and progresses, thereby providing an opportunity to ultimately improve diagnosis, treatment, and monitoring of COPD in both men and women.
Keywords: COPD; biological; sex; systematic review; women.
© 2020 Han.
Conflict of interest statement
MeiLan K. Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, and Novartis. She also reports research support from Novartis and Sunovion. Boehringer Ingelheim also supported conduction of the systematic search.
Figures


Similar articles
-
Disease of the airways in chronic obstructive pulmonary disease.Eur Respir J Suppl. 2001 Dec;34:41s-49s. doi: 10.1183/09031936.01.00234601. Eur Respir J Suppl. 2001. PMID: 12392034 Review.
-
Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.Am J Respir Crit Care Med. 2015 Jan 1;191(1):63-70. doi: 10.1164/rccm.201408-1423OC. Am J Respir Crit Care Med. 2015. PMID: 25393421
-
The Relationship of Educational Attainment with Pulmonary Emphysema and Airway Wall Thickness.Ann Am Thorac Soc. 2015 Jun;12(6):813-20. doi: 10.1513/AnnalsATS.201410-485OC. Ann Am Thorac Soc. 2015. PMID: 25822654
-
Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.COPD. 2014 Sep;11(5):503-9. doi: 10.3109/15412555.2014.933952. Epub 2014 Aug 5. COPD. 2014. PMID: 25093696
-
Impact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studies.Respirology. 2016 Feb;21(2):269-79. doi: 10.1111/resp.12661. Epub 2015 Nov 15. Respirology. 2016. PMID: 26567533 Review.
Cited by
-
Impact of Sex on Circulating Leukocytes Composition in COPD Patients.Int J Chron Obstruct Pulmon Dis. 2021 Dec 25;16:3539-3550. doi: 10.2147/COPD.S341623. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34992361 Free PMC article.
-
Pharmacovigilance Study on Adverse Events of Nicotine Replacement Therapy, Bupropion, and Varenicline in Patients with Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2025 May 15;20:1509-1524. doi: 10.2147/COPD.S514133. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40391127 Free PMC article.
-
Chronic obstructive pulmonary disease mortality trends in Spain, 1980-2020.Epidemiol Health. 2023;45:e2023036. doi: 10.4178/epih.e2023036. Epub 2023 Mar 18. Epidemiol Health. 2023. PMID: 36996868 Free PMC article.
-
Gender, tobacco and chronic obstructive pulmonary disease: analysis of the 2020 National Health Interview Survey.BMJ Open Respir Res. 2025 May 8;12(1):e002462. doi: 10.1136/bmjresp-2024-002462. BMJ Open Respir Res. 2025. PMID: 40340913 Free PMC article.
-
Host, Gender, and Early-Life Factors as Risks for Chronic Obstructive Pulmonary Disease.Clin Chest Med. 2020 Sep;41(3):329-337. doi: 10.1016/j.ccm.2020.06.009. Clin Chest Med. 2020. PMID: 32800188 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous